Infectious Disease In-vitro Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:

Description

The global Infectious Disease In-Vitro Diagnostics (IVD) market has been steadily growing and valued at approximately US$ 64 billion in 2024. With a projected Compound Annual Growth Rate (CAGR) of 5% over the next decade, the market is poised to reach nearly US$ 92 billion by the end of 2031. This growth is driven by the increasing need for early detection and control of infectious diseases such as severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), Ebola, chikungunya, avian flu, swine flu, and Zika, which have imposed a significant epidemiological burden. This article delves into the factors driving this growth, key market players, and the impact of recent events like the COVID-19 pandemic.

Sales Analysis of Infectious Disease In-Vitro Diagnostics Market

The rising burden of infectious diseases across the globe has increased the demand for diagnostic products. Notably, electronic medical records (IVDs) play a crucial role in patient care, influencing around 70% of medical decisions. While the majority of the IVD market is concentrated in developed countries, the United States, Europe, and Japan account for over 80% of global sales.

The United States is expected to maintain its position as the largest contributor to the Infectious Disease In-Vitro Diagnostics Market during the forecast period, with a projected absolute dollar opportunity exceeding US$ 9.4 billion over the next decade.

Key Drivers of the Infectious Disease In-Vitro Diagnostics Market

1. Rising Global Healthcare Spending: Approximately 10% of the world's GDP is allocated to global healthcare spending, steadily increasing due to the growing healthcare needs of the population. In-Vitro Diagnostics, which influences over 60% of clinical decisions in healthcare, represents only 2% of total healthcare costs. This presents a significant opportunity for affordable in-vitro diagnostics.
2. Government Support: Government funding plays a pivotal role in driving research institutions to develop rapid diagnostic systems capable of diagnosing various diseases using various samples. For example, the European Union's "recovery plan" involves an investment of over US$ 250 billion by the end of 2026.
3. Point of Care (POC) Testing: The delocalization of diagnostics, including auto-diagnostics and home diagnostics, is rapidly growing. Major manufacturing companies are focusing on releasing quick, portable, easy-to-use tools suitable for use outside of traditional laboratories. This trend is expected to enhance the accessibility of diagnostics.

Impact of COVID-19 on the Infectious Disease In-Vitro Diagnostics Market

The COVID-19 pandemic has significantly reshaped the diagnostic landscape, making in-vitro testing a cornerstone in the diagnosis of the virus. Various test kits, often authorized under emergency use authorizations (EUA), have been developed globally to detect COVID-19. One of the primary In-Vitro Diagnostics assays for COVID-19 relies on real-time reverse transcriptase-polymerase chain reaction (RT-PCR), capable of identifying the virus within hours. The simplified nature of diagnostic products during the pandemic has expedited market growth.

Challenges and Restraints

1. Macroeconomic Vulnerability: The diagnostic industry is more susceptible to changes in the macroeconomic cycle compared to other healthcare sectors, primarily due to exposure to industrial end markets like food testing, which tend to have higher macroeconomic vulnerability.
2. Regulatory Hurdles: Different regions have varying regulations governing the production and sale of in-vitro diagnostic instruments, which can lead to delays in regulatory approvals. This can result in wasted R&D expenditures if diagnostic products are rejected.
3. Stringent Reimbursement Policies: Reimbursement policies have become more stringent, particularly for creators of novel diagnostics. The coverage evaluation process can be opaque, leading to increased R&D costs and inefficiencies in the development of new diagnostic products.

Regional Insights

North America's Dominance: North America is expected to dominate the Infectious Disease In-Vitro Diagnostics Market, with the National Institutes of Health contributing significantly to scaling up diagnostic test production through its Rapid Acceleration of Diagnostics initiative. The introduction of innovative products is making the market more competitive.

Country-wise Insights

U.S. Market Analysis: The United States is poised to contribute over US$ 28 billion to the global Infectious Disease In-Vitro Diagnostics Market by 2031. While the majority of the IVD market is in developed countries, the U.S. market accounts for less than 50% of the global share. Point of Care (POC) diagnostics is anticipated to make up 12% of the country's overall IVD market.

U.K. Market Analysis: The U.K. market is expected to experience steady growth from 2024 to 2031, presenting a significant opportunity for expansion.

Japan Market Analysis:

The Japanese market is anticipated to show strong growth from 2024 to 2031, providing a substantial opportunity for development.

Competitive Landscape

Key companies operating in the Infectious Disease In-Vitro Diagnostics Market include Abbott Laboratories, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., bioMerieux SA, Siemens Healthineers AG, Danaher Corporation, Becton Dickinson and Company, PerkinElmer, Inc., Hologic, Inc., QIAGEN N.V., Grifols S.A., DiaSorin S.p.A, Bio-Rad Laboratories, Inc., Sysmex Corporation, Ortho Clinical Diagnostics Holdings plc, Quidel Corporation, Meridian Bioscience, Genetic Signatures Ltd., OraSure Technologies, Trinity Biotech Plc., Chembio Diagnostic Systems, Seegene, Inc., Co-Diagnostics, ELITechGroup, Epitope Diagnostics, Trivitron Healthcare, Meril Life Sciences Pvt. Ltd., InBios International, Vela Diagnostics, and Uniogen Oy.

Key Segments Covered in Infectious Disease In-Vitro Diagnostics Market Survey

By Product Type:

Instruments
Reagents
Services

By Technology:

Immunoassay
Molecular Diagnostics
Microbiology
Other Technologies

By Application:

MRSA
Streptococcus
Clostridium Difficile
Respiratory Virus
TB and Drug-resistant TB
Gonorrhea
HPV
HIV
Hepatitis C
Hepatitis B
COVID-19
Other Applications

By End-use:

Point of care
Central Laboratories
Other End-uses

By Region:

North America
Latin America
Europe
Asia Pacific
Middle East & Africa

1. Executive Summary

1.1. Global Infectious Disease In-vitro Diagnostics Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Infectious Disease In-vitro Diagnostics Market Outlook, 2018 - 2031

3.1. Global Infectious Disease In-vitro Diagnostics Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Instruments
  - 3.1.1.2. Reagents
  - 3.1.1.3. Services
3.2. Global Infectious Disease In-vitro Diagnostics Market Outlook, by Technology, Value (US$ Bn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Immunoassay
  - 3.2.1.2. Molecular Diagnostics
  - 3.2.1.3. Microbiology
  - 3.2.1.4. Other Technologies
3.3. Global Infectious Disease In-vitro Diagnostics Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. MRSA
  - 3.3.1.2. Streptococcus
  - 3.3.1.3. Clostridium Difficile
  - 3.3.1.4. Respiratory Virus
  - 3.3.1.5. TB and Drug-resistant TB
  - 3.3.1.6. Gonorrhea
  - 3.3.1.7. HPV
  - 3.3.1.8. HIV
  - 3.3.1.9. Hepatitis C
  - 3.3.1.10. Hepatitis B
  - 3.3.1.11. COVID-19
  - 3.3.1.12. Other Applications
3.4. Global Infectious Disease In-vitro Diagnostics Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. Point of care
  - 3.4.1.2. Central Laboratories
  - 3.4.1.3. Other End-uses
3.5. Global Infectious Disease In-vitro Diagnostics Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
- 3.5.1. Key Highlights
  - 3.5.1.1. North America
  - 3.5.1.2. Europe
  - 3.5.1.3. Asia Pacific
  - 3.5.1.4. Latin America
  - 3.5.1.5. Middle East & Africa

4. North America Infectious Disease In-vitro Diagnostics Market Outlook, 2018 - 2031

4.1. North America Infectious Disease In-vitro Diagnostics Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Instruments
  - 4.1.1.2. Reagents
  - 4.1.1.3. Services
4.2. North America Infectious Disease In-vitro Diagnostics Market Outlook, by Technology, Value (US$ Bn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Immunoassay
  - 4.2.1.2. Molecular Diagnostics
  - 4.2.1.3. Microbiology
  - 4.2.1.4. Other Technologies
4.3. North America Infectious Disease In-vitro Diagnostics Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. MRSA
  - 4.3.1.2. Streptococcus
  - 4.3.1.3. Clostridium Difficile
  - 4.3.1.4. Respiratory Virus
  - 4.3.1.5. TB and Drug-resistant TB
  - 4.3.1.6. Gonorrhea
  - 4.3.1.7. HPV
  - 4.3.1.8. HIV
  - 4.3.1.9. Hepatitis C
  - 4.3.1.10. Hepatitis B
  - 4.3.1.11. COVID-19
  - 4.3.1.12. Other Applications
4.4. North America Infectious Disease In-vitro Diagnostics Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. Point of care
  - 4.4.1.2. Central Laboratories
  - 4.4.1.3. Other End-uses
- 4.4.2. BPS Analysis/Market Attractiveness Analysis
4.5. North America Infectious Disease In-vitro Diagnostics Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 4.5.1. Key Highlights
  - 4.5.1.1. U.S. Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2018 - 2031
  - 4.5.1.2. U.S. Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2018 - 2031
  - 4.5.1.3. U.S. Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2018 - 2031
  - 4.5.1.4. U.S. Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
  - 4.5.1.5. Canada Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2018 - 2031
  - 4.5.1.6. Canada Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2018 - 2031
  - 4.5.1.7. Canada Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2018 - 2031
  - 4.5.1.8. Canada Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
- 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Infectious Disease In-vitro Diagnostics Market Outlook, 2018 - 2031

5.1. Europe Infectious Disease In-vitro Diagnostics Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Instruments
  - 5.1.1.2. Reagents
  - 5.1.1.3. Services
5.2. Europe Infectious Disease In-vitro Diagnostics Market Outlook, by Technology, Value (US$ Bn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Immunoassay
  - 5.2.1.2. Molecular Diagnostics
  - 5.2.1.3. Microbiology
  - 5.2.1.4. Other Technologies
5.3. Europe Infectious Disease In-vitro Diagnostics Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. MRSA
  - 5.3.1.2. Streptococcus
  - 5.3.1.3. Clostridium Difficile
  - 5.3.1.4. Respiratory Virus
  - 5.3.1.5. TB and Drug-resistant TB
  - 5.3.1.6. Gonorrhea
  - 5.3.1.7. HPV
  - 5.3.1.8. HIV
  - 5.3.1.9. Hepatitis C
  - 5.3.1.10. Hepatitis B
  - 5.3.1.11. COVID-19
  - 5.3.1.12. Other Applications
5.4. Europe Infectious Disease In-vitro Diagnostics Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Point of care
  - 5.4.1.2. Central Laboratories
  - 5.4.1.3. Other End-uses
- 5.4.2. BPS Analysis/Market Attractiveness Analysis
5.5. Europe Infectious Disease In-vitro Diagnostics Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 5.5.1. Key Highlights
  - 5.5.1.1. Germany Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.5.1.2. Germany Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2018 - 2031
  - 5.5.1.3. Germany Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.4. Germany Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.5.1.5. U.K. Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.5.1.6. U.K. Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2018 - 2031
  - 5.5.1.7. U.K. Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.8. U.K. Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.5.1.9. France Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.5.1.10. France Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2018 - 2031
  - 5.5.1.11. France Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.12. France Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.5.1.13. Italy Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.5.1.14. Italy Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2018 - 2031
  - 5.5.1.15. Italy Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.16. Italy Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.5.1.17. Turkey Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.5.1.18. Turkey Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2018 - 2031
  - 5.5.1.19. Turkey Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.20. Turkey Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.5.1.21. Russia Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.5.1.22. Russia Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2018 - 2031
  - 5.5.1.23. Russia Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.24. Russia Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.5.1.25. Rest of Europe Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2018 - 2031
  - 5.5.1.26. Rest of Europe Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2018 - 2031
  - 5.5.1.27. Rest of Europe Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.28. Rest of Europe Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
- 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Infectious Disease In-vitro Diagnostics Market Outlook, 2018 - 2031

6.1. Asia Pacific Infectious Disease In-vitro Diagnostics Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Instruments
  - 6.1.1.2. Reagents
  - 6.1.1.3. Services
6.2. Asia Pacific Infectious Disease In-vitro Diagnostics Market Outlook, by Technology, Value (US$ Bn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Immunoassay
  - 6.2.1.2. Molecular Diagnostics
  - 6.2.1.3. Microbiology
  - 6.2.1.4. Other Technologies
6.3. Asia Pacific Infectious Disease In-vitro Diagnostics Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. MRSA
  - 6.3.1.2. Streptococcus
  - 6.3.1.3. Clostridium Difficile
  - 6.3.1.4. Respiratory Virus
  - 6.3.1.5. TB and Drug-resistant TB
  - 6.3.1.6. Gonorrhea
  - 6.3.1.7. HPV
  - 6.3.1.8. HIV
  - 6.3.1.9. Hepatitis C
  - 6.3.1.10. Hepatitis B
  - 6.3.1.11. COVID-19
  - 6.3.1.12. Other Applications
6.4. Asia Pacific Infectious Disease In-vitro Diagnostics Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. Point of care
  - 6.4.1.2. Central Laboratories
  - 6.4.1.3. Other End-uses
- 6.4.2. BPS Analysis/Market Attractiveness Analysis
6.5. Asia Pacific Infectious Disease In-vitro Diagnostics Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 6.5.1. Key Highlights
  - 6.5.1.1. China Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2018 - 2031
  - 6.5.1.2. China Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2018 - 2031
  - 6.5.1.3. China Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.4. China Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.5.1.5. Japan Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2018 - 2031
  - 6.5.1.6. Japan Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2018 - 2031
  - 6.5.1.7. Japan Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.8. Japan Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.5.1.9. South Korea Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2018 - 2031
  - 6.5.1.10. South Korea Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2018 - 2031
  - 6.5.1.11. South Korea Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.12. South Korea Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.5.1.13. India Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2018 - 2031
  - 6.5.1.14. India Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2018 - 2031
  - 6.5.1.15. India Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.16. India Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.5.1.17. Southeast Asia Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2018 - 2031
  - 6.5.1.18. Southeast Asia Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2018 - 2031
  - 6.5.1.19. Southeast Asia Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.20. Southeast Asia Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.5.1.21. Rest of Asia Pacific Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2018 - 2031
  - 6.5.1.22. Rest of Asia Pacific Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2018 - 2031
  - 6.5.1.23. Rest of Asia Pacific Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.24. Rest of Asia Pacific Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
- 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Infectious Disease In-vitro Diagnostics Market Outlook, 2018 - 2031

7.1. Latin America Infectious Disease In-vitro Diagnostics Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Instruments
  - 7.1.1.2. Reagents
  - 7.1.1.3. Services
7.2. Latin America Infectious Disease In-vitro Diagnostics Market Outlook, by Technology, Value (US$ Bn), 2018 - 2031
7.3. Latin America Infectious Disease In-vitro Diagnostics Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. MRSA
  - 7.3.1.2. Streptococcus
  - 7.3.1.3. Clostridium Difficile
  - 7.3.1.4. Respiratory Virus
  - 7.3.1.5. TB and Drug-resistant TB
  - 7.3.1.6. Gonorrhea
  - 7.3.1.7. HPV
  - 7.3.1.8. HIV
  - 7.3.1.9. Hepatitis C
  - 7.3.1.10. Hepatitis B
  - 7.3.1.11. COVID-19
  - 7.3.1.12. Other Applications
7.4. Latin America Infectious Disease In-vitro Diagnostics Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Point of care
  - 7.4.1.2. Central Laboratories
  - 7.4.1.3. Other End-uses
- 7.4.2. BPS Analysis/Market Attractiveness Analysis
7.5. Latin America Infectious Disease In-vitro Diagnostics Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 7.5.1. Key Highlights
  - 7.5.1.1. Brazil Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2018 - 2031
  - 7.5.1.2. Brazil Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2018 - 2031
  - 7.5.1.3. Brazil Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.5.1.4. Brazil Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.5.1.5. Mexico Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2018 - 2031
  - 7.5.1.6. Mexico Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2018 - 2031
  - 7.5.1.7. Mexico Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.5.1.8. Mexico Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.5.1.9. Argentina Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2018 - 2031
  - 7.5.1.10. Argentina Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2018 - 2031
  - 7.5.1.11. Argentina Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.5.1.12. Argentina Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.5.1.13. Rest of Latin America Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2018 - 2031
  - 7.5.1.14. Rest of Latin America Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2018 - 2031
  - 7.5.1.15. Rest of Latin America Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.5.1.16. Rest of Latin America Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
- 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Infectious Disease In-vitro Diagnostics Market Outlook, 2018 - 2031

8.1. Middle East & Africa Infectious Disease In-vitro Diagnostics Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Instruments
  - 8.1.1.2. Reagents
  - 8.1.1.3. Services
8.2. Middle East & Africa Infectious Disease In-vitro Diagnostics Market Outlook, by Technology, Value (US$ Bn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Immunoassay
  - 8.2.1.2. Molecular Diagnostics
  - 8.2.1.3. Microbiology
  - 8.2.1.4. Other Technologies
8.3. Middle East & Africa Infectious Disease In-vitro Diagnostics Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. MRSA
  - 8.3.1.2. Streptococcus
  - 8.3.1.3. Clostridium Difficile
  - 8.3.1.4. Respiratory Virus
  - 8.3.1.5. TB and Drug-resistant TB
  - 8.3.1.6. Gonorrhea
  - 8.3.1.7. HPV
  - 8.3.1.8. HIV
  - 8.3.1.9. Hepatitis C
  - 8.3.1.10. Hepatitis B
  - 8.3.1.11. COVID-19
  - 8.3.1.12. Other Applications
8.4. Middle East & Africa Infectious Disease In-vitro Diagnostics Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. Point of care
  - 8.4.1.2. Central Laboratories
  - 8.4.1.3. Other End-uses
- 8.4.2. BPS Analysis/Market Attractiveness Analysis
8.5. Middle East & Africa Infectious Disease In-vitro Diagnostics Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 8.5.1. Key Highlights
  - 8.5.1.1. GCC Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2018 - 2031
  - 8.5.1.2. GCC Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2018 - 2031
  - 8.5.1.3. GCC Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.4. GCC Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.5.1.5. South Africa Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2018 - 2031
  - 8.5.1.6. South Africa Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2018 - 2031
  - 8.5.1.7. South Africa Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.8. South Africa Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.5.1.9. Egypt Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2018 - 2031
  - 8.5.1.10. Egypt Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2018 - 2031
  - 8.5.1.11. Egypt Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.12. Egypt Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.5.1.13. Nigeria Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2018 - 2031
  - 8.5.1.14. Nigeria Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2018 - 2031
  - 8.5.1.15. Nigeria Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.16. Nigeria Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.5.1.17. Rest of Middle East & Africa Infectious Disease In-vitro Diagnostics Market by Product, Value (US$ Bn), 2018 - 2031
  - 8.5.1.18. Rest of Middle East & Africa Infectious Disease In-vitro Diagnostics Market by Technology, Value (US$ Bn), 2018 - 2031
  - 8.5.1.19. Rest of Middle East & Africa Infectious Disease In-vitro Diagnostics Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.20. Rest of Middle East & Africa Infectious Disease In-vitro Diagnostics Market by End User, Value (US$ Bn), 2018 - 2031
- 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Product vs Application Heatmap
9.2. Manufacturer vs Indication Heatmap
9.3. Company Market Share Analysis, 2022
9.4. Competitive Dashboard
9.5. Company Profiles
- 9.5.1. Abbott Laboratories
  - 9.5.1.1. Company Overview
  - 9.5.1.2. Product Portfolio
  - 9.5.1.3. Financial Overview
  - 9.5.1.4. Business Strategies and Development
- 9.5.2. Thermo Fisher Scientific Inc.
  - 9.5.2.1. Company Overview
  - 9.5.2.2. Product Portfolio
  - 9.5.2.3. Financial Overview
  - 9.5.2.4. Business Strategies and Development
- 9.5.3. F. Hoffmann-La Roche Ltd.
  - 9.5.3.1. Company Overview
  - 9.5.3.2. Product Portfolio
  - 9.5.3.3. Financial Overview
  - 9.5.3.4. Business Strategies and Development
- 9.5.4. bioMerieux SA
  - 9.5.4.1. Company Overview
  - 9.5.4.2. Product Portfolio
  - 9.5.4.3. Financial Overview
  - 9.5.4.4. Business Strategies and Development
- 9.5.5. Siemens Healthineers AG
  - 9.5.5.1. Company Overview
  - 9.5.5.2. Product Portfolio
  - 9.5.5.3. Financial Overview
  - 9.5.5.4. Business Strategies and Development
- 9.5.6. Danaher Corporation
  - 9.5.6.1. Company Overview
  - 9.5.6.2. Product Portfolio
  - 9.5.6.3. Financial Overview
  - 9.5.6.4. Business Strategies and Development
- 9.5.7. Becton Dickinson and Company
  - 9.5.7.1. Company Overview
  - 9.5.7.2. Product Portfolio
  - 9.5.7.3. Financial Overview
  - 9.5.7.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations